日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prognostic value of skeletal muscle viscoelasticity in older patients with heart failure: the VISMARC-HF study design

骨骼肌粘弹性对老年心力衰竭患者预后的价值:VISMARC-HF 研究设计

Nagaoka, Ryohei; Katano, Satoshi; Yano, Toshiyuki; Kawai, Makoto; Adachi, Risa; Nakata, Kei; Habaguchi, Aki; Yamano, Kotaro; Ohori, Katsuhiko; Kouzu, Hidemichi; Katayose, Masaki; Furuhashi, Masato; Taniguchi, Keigo; Umemoto, Yasunori

Protective association of renin-angiotensin system inhibitor use with skeletal muscle wasting in diabetic heart failure

肾素-血管紧张素系统抑制剂的使用与糖尿病心力衰竭患者的骨骼肌萎缩具有保护作用

Kouzu, Hidemichi; Yano, Toshiyuki; Katano, Satoshi; Kawaharata, Wataru; Numazawa, Ryo; Nagaoka, Ryohei; Aida, Hiroki; Ohori, Katsuhiko; Fujito, Takefumi; Nagano, Nobutaka; Furuhashi, Masato

An Apparent Association of Metabolic Dysfunction-Associated Steatotic Liver Disease with High Levels of Estimated Small Dense LDL Cholesterol in a Japanese Population

日本人群中代谢功能障碍相关脂肪肝与高水平估计小而密LDL胆固醇之间存在明显关联

Matsumori, Rie; Tanaka, Marenao; Sato, Tatsuya; Akiyama, Yukinori; Hosaka, Itaru; Nakata, Kei; Kawaharata, Wataru; Aida, Hiroki; Nishizawa, Keitaro; Kouzu, Hidemichi; Yama, Naoya; Hanawa, Nagisa; Furuhashi, Masato

Right Bundle Branch Conduction in Left Bundle Branch Area Pacing

左束支区域起搏引起的右束支传导

Fujito, Takefumi; Erata, Kento; Noumura, Naoto; Mochizuki, Atsushi; Furuhashi, Masato

Association of Difference Between eGFR From Cystatin C and Creatinine and Serum GDF-15 With Adverse Outcomes in Diabetes Mellitus.

胱抑素 C 和肌酐与血清 GDF-15 的 eGFR 差异与糖尿病不良预后的相关性

Gohda Tomohito, Kamei Nozomu, Tanaka Marenao, Furuhashi Masato, Sato Tatsuya, Kubota Mitsunobu, Sanuki Michiyoshi, Koshida Takeo, Hagiwara Shinji, Suzuki Yusuke, Murakoshi Maki

Incorporation of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Health Stage of Cardiovascular-Kidney-Metabolic Syndrome Improves Predictive Ability for Coronary Artery Disease in a Japanese General Population

将代谢功能障碍相关的脂肪肝疾病纳入心血管-肾脏-代谢综合征的健康阶段,可提高日本普通人群冠状动脉疾病的预测能力

Kawaharata, Wataru; Tanaka, Marenao; Sato, Tatsuya; Akiyama, Yukinori; Hosaka, Itaru; Aida, Hiroki; Matsumori, Rie; Nakata, Kei; Nishizawa, Keitaro; Suzuki, Toru; Kouzu, Hidemichi; Hanawa, Nagisa; Furuhashi, Masato

Unraveling Novel Subsets of Lymphocytes Involved in Sac Expansion in the Tertiary Lymphoid Structure Within an Abdominal Aortic Aneurysm.

揭示腹主动脉瘤三级淋巴结构中参与囊扩张的新型淋巴细胞亚群

Hosaka Itaru, Ikegami Ippei, Mikami Takuma, Sato Tatsuya, Ogawa Toshifumi, Mukawa Kei, Tanaka Marenao, Endo Keisuke, Akiyama Yukinori, Ohkawa Akihito, Nakazawa Junji, Shibata Tsuyoshi, Nakajima Tomohiro, Iba Yutaka, Shiiku Chikara, Sumino Satoshi, Koshima Ryuji, Takano Kenichi, Ichimiya Shingo, Kawaharada Nobuyoshi, Furuhashi Masato

Expression and Secretion of Intraocular Fatty Acid-Binding Protein 4 (ioFABP4) and 5 (ioFABP5) Are Regulated by Glucose Levels and Fatty Acids

眼内脂肪酸结合蛋白4(ioFABP4)和5(ioFABP5)的表达和分泌受葡萄糖水平和脂肪酸的调节

Ohguro, Hiroshi; Higashide, Megumi; Ishiwata, Erika; Hikage, Fumihito; Watanabe, Megumi; Nishikiori, Nami; Sato, Tatsuya; Furuhashi, Masato

Comparison of the effects of pemafibrate and omega-3 fatty acid ethyl on fatty liver index in patients with dyslipidemia treated with statin: a sub-analysis from the PROUD48 study

比较培马贝特和ω-3脂肪酸乙酯对接受他汀类药物治疗的血脂异常患者脂肪肝指数的影响:PROUD48研究的亚组分析

Takeda, Yasutaka; Furuhashi, Masato; Sakuma, Ichiro; Hiramitsu, Shinya; Okada, Mizuho; Ueda, Shinichiro; Kumashiro, Naoki; Sakurai, Masaru

Treatment with pemafibrate ameliorates fatty liver index and atherogenic lipid profiles in Japanese patients with type 2 diabetes mellitus

培马贝特治疗可改善日本2型糖尿病患者的脂肪肝指数和致动脉粥样硬化脂质谱

Suzuki, Toru; Sato, Tatsuya; Tanaka, Marenao; Nakata, Kei; Endo, Keisuke; Aida, Hiroki; Kawaharata, Wataru; Hosaka, Itaru; Umetsu, Araya; Ogawa, Toshifumi; Akiyama, Yukinori; Furuhashi, Masato